Zura Bio Limited
NASDAQ Capital MarketTotal Valuation
Zura Bio Limited carries a market capitalization of 365.11M, placing it among publicly traded companies globally.
| Market Cap | 365.11M |
| Enterprise Value | N/A |
Share Statistics
Zura Bio Limited currently has 95.42M shares outstanding.
| Shares Outstanding | 95.42M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 2.86 |
| P/TBV Ratio | 2.86 |
| P/FCF Ratio | -8.47 |
| P/OCF Ratio | -8.46 |
Financial Position
Zura Bio Limited maintains a current ratio of 12.90, meaning it holds 12.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 12.90 |
| Quick Ratio | 12.57 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -53.09 |
| Return on Assets (ROA) | -46.20 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -81,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Zura Bio Limited's stock has gained approximately 13.05638% over the past 52 weeks. The 50-day moving average sits at 5.03, while the 200-day moving average is 5.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.05638% |
| 50-Day Moving Average | 5.03 |
| 200-Day Moving Average | 5.30 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -92.69M, while operating income came in at -92.75M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -92.75M |
| Pretax Income | -85.82M |
| Net Income | -85.74M |
| EBITDA | -92.69M |
| EBIT | -92.75M |
| Earnings Per Share (EPS) | -0.77 |
Balance Sheet
Total book value stands at 197.09M, with working capital of 194.18M providing operational flexibility.
| Cash & Cash Equivalents | 205.13M |
| Total Debt | N/A |
| Net Debt | -205.13M |
| Equity (Book Value) | 197.09M |
| Book Value Per Share | 2.07 |
| Working Capital | 194.18M |
Cash Flow
Zura Bio Limited produced -77.55M in operating cash flow over the past twelve months. After subtracting -86,000.00 in capital expenditures, free cash flow totaled -77.63M - equivalent to -0.70 per share.
| Operating Cash Flow | -77.55M |
| Capital Expenditures | -86,000.00 |
| Free Cash Flow | -77.63M |
| FCF Per Share | -0.70 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -22.78 |
| FCF Yield | -11.81 |
Scores
Zura Bio Limited posts an Altman Z-Score of 18.55, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 18.55 |